Drugs that contain Levocarnitine
1. Carnitor patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6696493 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodic dialysis |
Jan, 2021
(3 years ago) | |
| US6335369 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) | |
| US6429230 | LEADIANT BIOSCI INC | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) | |
Market Authorisation Date: 16 December, 1992
Treatment: Use of levocarnitine in prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CARNITOR family patents
